BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38183101)

  • 21. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy.
    Piana A; Sotgiu G; Castiglia P; Pischedda S; Cocuzza C; Capobianco G; Marras V; Dessole S; Muresu E
    BMC Public Health; 2011 Oct; 11():785. PubMed ID: 21989375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and type distribution of human papillomavirus infection using the INNo-Lipa assay, Kerman, Southeast Iran.
    Afshar RM; Mollaie HR; Fazlalipour M; Arabzadeh SA
    Asian Pac J Cancer Prev; 2013; 14(9):5287-91. PubMed ID: 24175815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low concordance of oral and genital HPV infection among male patients with sexually transmitted infections in Vietnam.
    Le HHL; Bi X; Ishizaki A; Van Le H; Nguyen TV; Ichimura H
    BMC Infect Dis; 2019 Jul; 19(1):578. PubMed ID: 31272409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of human papillomavirus infection in non-vaccinated young males: low clearance probability in high-risk genotypes.
    Cai T; Perletti G; Meacci F; Magri V; Verze P; Palmieri A; Mazzoli S; Santi R; Nesi G; Mirone V; Bartoletti R
    Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):463-9. PubMed ID: 26753992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence and genotype of human papillomavirus on cervical samples from an Irish female population with external genital warts.
    Cremin S; Menton JF; Canier L; Horgan M; Fanning LJ
    Hum Vaccin Immunother; 2012 Jul; 8(7):916-20. PubMed ID: 22777095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
    Broomall EM; Reynolds SM; Jacobson RM
    Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T; Dube Mandishora R; Borok M
    Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular epidemiology of sexually transmitted human papillomavirus in a self referred group of women in Ireland.
    Menton JF; Cremin SM; Canier L; Horgan M; Fanning LJ
    Virol J; 2009 Jul; 6():112. PubMed ID: 19627586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of high and low-risk human papillomavirus genotypes increases the risk of developing genital warts: A population-based cohort study.
    Hasanzadeh M; Rejali M; Mehramiz M; Akbari M; Mousavi Seresht L; Yazdandoost Y; Farokhi S; Mahdian Z; Maleki F; Emamdadi-Aliabad Z; Jalilvand N; Khorrami S; Fadaei Z; Movahedi M; Hosseini Z; Razmi F; Takamoli T; Ferns GA; Avan A
    J Cell Biochem; 2019 Aug; 120(8):12870-12874. PubMed ID: 30868650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus infection in females with normal cervical cytology: Genotyping and phylogenetic analysis among women in Punjab, Pakistan.
    Aziz H; Iqbal H; Mahmood H; Fatima S; Faheem M; Sattar AA; Tabassum S; Napper S; Batool S; Rasheed N
    Int J Infect Dis; 2018 Jan; 66():83-89. PubMed ID: 29138009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
    J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Frequency and Typing of HPV Virus Among Suspected Women Referred to HPV Genotyping Test in Mazandaran, Northern Iran.
    Hosseini E; Yaghoubian SS; Hashemi-Soteh SMB
    Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China.
    Wang L; Wang P; Ren Y; Du J; Jiang J; Jia X; Chen C; Wang Y
    PLoS One; 2016; 11(8):e0160698. PubMed ID: 27494179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
    Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
    PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
    Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
    J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study.
    Debrah O; Agyemang-Yeboah F; Donkoh ET; Asmah RH
    BMC Womens Health; 2021 Oct; 21(1):372. PubMed ID: 34702246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018.
    Rosenblum HG; Lewis RM; Gargano JW; Querec TD; Unger ER; Markowitz LE
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):415-420. PubMed ID: 33764964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.